BioPhorum Article on Resilience of the Supply Chain
Recommendation

22 October 2026
Good Distribution Practice of Active Substances for Human and Veterinary Medicinal Products
BioPhorum recently published a new document entitled "Restarting the inbound supply chain: a BioPhorum Supply Partnering and Relationship Management position paper".
In the background and introduction chapter, the authors write: "Currently in the aftermath of the COVID-19 pandemic, the impact of overstocking and contingency purchasing on the supply chain is ongoing. This subject was outlined at a high level in the article Collaborating to solve supply chain issues by Bob Brooks, Nicola Coles and Lesley Holt, published in Pharmaceutical Manufacturing and Packaging Sourcer (Feb 2024). This paper from the BioPhorum Supply Resilience’s Supply Partnering and Relationship Management (SPRM) Team drills down into problems and potential solutions related to the inbound supply chain."
Key topics of the new document include:
- Ordering strategies
- Flexibility in material use
- Capacity planning
- Risk sharing
The document concludes that continuous communication and adaptive strategies between stakeholders are essential for creating a resilient and agile supply chain. BioPhorum proposes frameworks for regular updates, best practices, and structured collaboration to prevent future disruptions.
You can download the paper from the BioPhorum website.
Related GMP News
30.09.2026European GDP Association Developments May through August 2026
30.09.2026Warehouse Temperature Excursions: What Does the FDA Expect?
30.09.2026Version 4.0 of the Swissmedic Document on Notifications of Changes Published
30.09.2026USA: Court Stops Warehouse Activities Following Persistent Insanitary Warehouse Conditions
30.09.2026GDP Non-Compliance Report: CAPA Measures must not only be Promised but also Implemented
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September


